Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search

Commentary

 

Apr 21 2020

Jay Battacharya is a Stanford University based physician and economist.  We shared a video of a discussion with him on coronavirus issues a couple of weeks ago.  Here is a followup in which he talks about where we are now, including his work on antibody prevalence studies and the need to take into account the health harms of the lockdown.

https://www.youtube.com/watch?v=k7v2F3usNVA&list=PLq8BgDugd2oyqmYx6RdVlJfQeAdhJkhc3
Apr 20 2020

We Are Destroying Our Health Care System

By Kevin Roche Commentary 2 Comments
The evidence mounts that the extreme lockdown is devastating the health care sector along with other industries.
Read More
Apr 20 2020

More and More Evidence of the True Infected Rate

By Kevin Roche Commentary No Comments
A Los Angeles County study for antibodies to coronavirus finds that there are 28 to 55 times more cases than are shown by testing.
Read More
Apr 20 2020

The Governor Speaks, I Try to Interpret Reality

By Kevin Roche Commentary 2 Comments
Beneath Governor Walz' confident pronunciations about the epidemic are some ugly truths.
Read More
Apr 20 2020

Drowning in Coronavirus Research, Part Deux

By Kevin Roche Commentary No Comments
Summaries of research papers on infection rates and transmission dynamics.
Read More
Apr 19 2020

Drowning in Coronavirus Research, Part I

By Kevin Roche Commentary No Comments
Some more research or coronavirus story summaries, with the less dense ones up first.
Read More
Apr 19 2020

Its Not an Overreaction, Its an Unwise Reaction

By Kevin Roche Commentary No Comments
Bad decision-making process inevitably leads to bad decisions, and that is where we are.
Read More
Apr 18 2020

The Modelers Respond to Minnesota Legislators’ Questions and I Respond to The Modelers

By Kevin Roche Commentary One Comment
Here are responses Minnesota's modelers gave to legislators' questions and my response to the responses.
Read More
Apr 18 2020

Too Much Swedish Sense

By Kevin Roche Commentary No Comments
A senior epidemiologist gives a much more common-sense view of the epidemic.
Read More
Apr 18 2020

More on the Stanford Antibody Study

By Kevin Roche Commentary No Comments
Here is the text and analysis of the full Stanford antibody study paper.
Read More
  • « Previous
  • 1
  • …
  • 368
  • 369
  • 370
  • 371
  • 372
  • …
  • 660
  • Next »

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

There is some weird angle here, as Angle Health raises $600 million in a new capital round, but it appears some of it is to provide liquidity to existing shareholders....
September 22, 2026
More AI craziness in health care.  A company called H1 is buying Defacto Health for God-knows how much money.  Both companies claim an AI background and to help with “provider...
September 11, 2026
To show you how AI fever has infected every part of the investing world, this company, Forus, raised $150 million in new capital at a $3 billion valuation by saying...
September 9, 2026
Thyme Care decides its time to party, spicing up its business with a fresh $125 million in capital, with a valuation of over $2 billion.  The company helps manage cancer...
September 3, 2026

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1845) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1726) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Congressional Budget Office
  • Health Affairs

RSS Feed

RSS feed

© 2026 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts